- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Dietary Management of Metabolic Liver Disease ; volume:22 ; number:1 ; day:2 ; month:2 ; year:2023 ; pages:24-32 ; date:3.2023
Current hepatology reports ; 22, Heft 1 (2.2.2023), 24-32, 3.2023
- Urheber
-
Kaenkumchorn, Tanyaporn K.
Patel, Shreena
Berenhaut, Esther
Kohli, Rohit
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11901-023-00599-3
- URN
-
urn:nbn:de:101:1-2409060951581.142921205892
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaenkumchorn, Tanyaporn K.
- Patel, Shreena
- Berenhaut, Esther
- Kohli, Rohit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dietary patterns and metabolic dysfunction-associated fatty liver disease in China’s multi-ethnic regions
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
Biochemical assessment of metabolic associated fatty liver disease
Dietary inorganic nitrate: From villain to hero in metabolic disease?
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Dietary patterns and risk of non-alcoholic fatty liver disease
Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: a cross-sectional study from NHANES
The heart‐liver metabolic axis: defective communication exacerbates disease
Dietary wheat amylase trypsin inhibitors worsen chronic liver disease in preclinical models of non-alcoholic fatty liver disease and liver fibrosis
Pitfalls in the management of metabolic liver diseases (debate)
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
Dietary patterns and metabolic dysfunction-associated fatty liver disease in China’s multi-ethnic regions
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
Biochemical assessment of metabolic associated fatty liver disease
Dietary inorganic nitrate: From villain to hero in metabolic disease?
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Dietary patterns and risk of non-alcoholic fatty liver disease
Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: a cross-sectional study from NHANES
The heart‐liver metabolic axis: defective communication exacerbates disease
Dietary wheat amylase trypsin inhibitors worsen chronic liver disease in preclinical models of non-alcoholic fatty liver disease and liver fibrosis
Pitfalls in the management of metabolic liver diseases (debate)
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
Dietary patterns and metabolic dysfunction-associated fatty liver disease in China’s multi-ethnic regions
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
Biochemical assessment of metabolic associated fatty liver disease
Dietary inorganic nitrate: From villain to hero in metabolic disease?
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Dietary patterns and risk of non-alcoholic fatty liver disease
Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: a cross-sectional study from NHANES
The heart‐liver metabolic axis: defective communication exacerbates disease
Dietary wheat amylase trypsin inhibitors worsen chronic liver disease in preclinical models of non-alcoholic fatty liver disease and liver fibrosis
Pitfalls in the management of metabolic liver diseases (debate)